OMG takes pounds 2.5m antibiotics stake
OMG takes pounds 2.5m antibiotics stake
OXFORD Molecular Group (OMG), the provider of IT and drug discovery research services to the biotechnology and pharmaceutical industries, is investing pounds 2.5m in MicroGenics, a new company aimed at speeding up the development of antibiotics. The company was formed by Professor Jeff Errington of the University of Oxford. The professor, the university and OMG will have stakes in the company.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies